On September 13, 2023, Shenzhen Cell Valley Chairman Professor Shi Yuanyuan, Chief scientist Professor Wang Jianxun, Deputy General manager Tang Xiaomeng, Assistant Chairman Wei Zheng, international cell medicine expert Dr. Zhan Jianqiang, President of Cell Medicine Branch of China Food and Drug Promotion Association, Director Chen Junhui of Interventional and Cell Therapy Center of Shenzhen Hospital of Peking University, and other delegation visited Shantou Academy of Medical Sciences. President Xu Haixiong of Shantou Academy of Medical Sciences, Director Li Yongqian of Hematology Department of Shantou Central Hospital, and Dr. Zhuang Zerui of Neurosurgery Department of Shantou Central Hospital warmly received and conducted discussions and exchanges.

First of all, under the leadership of Xu Haixiong, president of Shantou Academy of Medical Sciences and former president of Shantou Central Hospital, the representatives of all parties visited the laboratory center and biobank of Shantou Central Hospital to deeply understand the construction of its scientific research platform, advanced facilities and equipment and clinical practice.

At the symposium, President Xu Haixiong, Professor Shi Yuanyuan and Dr. Zhan Jianqiang successively introduced their respective team building and team development advantages in detail.

President Xu Haixiong extended a warm welcome to the visiting delegations. It is also hoped that through this exchange visit, multi-party cooperation and exchanges can be established, medical scientific research cooperation can be further strengthened, and personnel training and exchanges can be promoted. Jointly promote the innovation and development of Shantou Academy of Medical Sciences in the field of cell therapy.

Professor Shi Yuanyuan introduced the latest research achievements and innovative projects of Shenzhen Cell Valley in the field of cell therapy to the participants. It emphasized the technical strength and R&D capability of Shenzhen Cell Valley in the field of cell therapy, and expressed its willingness to cooperate with Shantou Academy of Medical Sciences to jointly promote innovative research and product development in the field of cell therapy.

Dr. Zhan Jianqiang proposed that through this exchange visit, he hoped to jointly establish an international Comprehensive Life Medicine Science Innovation Center and Shantou International High-end Medical Center on the existing basis, and promote the improvement of the high-end medical level of Shantou Academy of Medical Sciences. Interdisciplinary cooperation to carry out cutting-edge research and innovative projects, promote the development and application of medical science, and provide high-quality medical services to patients at home and abroad.

Chen Junhui, director of Shantou Academy of Medical Sciences, said that Shantou Academy of Medical Sciences can learn from its experience and development advantages in team building in the field of cell therapy, multi-disciplinary formation, in order to give full play to their respective professional and technical advantages, and promote the development and innovation of Shantou Academy of Medical Sciences in the field of cell therapy.

All parties expressed that they will rely on the platform construction of Shantou Academy of Medical Sciences to deepen medical scientific research cooperation and achieve multi-disciplinary collaborative innovation. By bringing together the expertise and technical advantages of different disciplines, we can better solve the problems of diagnosis and treatment of complex diseases, and improve the medical level and treatment effect. In order to promote the construction and development of the Academy of Medical Sciences and clinical applications, to provide patients with more advanced medical technology and treatment programs, to promote the development of medical technology and the improvement of medical services.